Role of dose selection in successful interleukin-2 immunotherapy: solving the Goldilock’s Complex

Podobne zapisy

• Combination immunotherapy with Interleukin-2 and CTLA-4 blockade decreases tumor growth and improves overall survival
  od: Broucek, Joseph R, i wsp.
  Wydane: (2013)
• Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment
  od: Broucek, Joseph, i wsp.
  Wydane: (2014)
• Acute viral infection results in a PD-1-dependent loss of anti-tumor CD8+ T cell responses: implications for tumor immunotherapy
  od: Kohlhapp, Frederick, i wsp.
  Wydane: (2015)
• Single-step nanoparticle antigen presentation system for tumor immunotherapy
  od: Kohlhapp, Frederick, i wsp.
  Wydane: (2015)
• The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma
  od: Hughes, Tasha, i wsp.
  Wydane: (2015)